Source:http://linkedlifedata.com/resource/pubmed/id/15361250
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2004-9-13
|
pubmed:abstractText |
Leishmania major infections induce the development of a CD4(+) T-helper 1 (Th1) response that not only controls the primary infection but also results in life-long immunity to reinfection. How that immunity is maintained is unknown, although because of the existence of infection-induced immunity, there has been an assumption that the development of a vaccine against leishmaniasis would be relatively easy. This has turned out not to be the case. One problem has been the finding that a large part of the immunity induced by a primary infection depends upon the presence of persistent parasites. Nevertheless, there are ample situations where immunologic memory persists without the continued presence of antigen, providing the prospect that a non-live vaccine for leishmaniasis can be developed. To do so will require an understanding of the events involved in the development of an effective protective T-cell response and, more importantly, an understanding of how to maintain that response. Here, we review work from our laboratory, describing how Th1 cells develop in L. major-infected mice, the nature of the memory T cells that provide protection to reinfection, and how that information may be utilized in the development of vaccines.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0105-2896
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
201
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
318-38
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15361250-Animals,
pubmed-meshheading:15361250-Drug Design,
pubmed-meshheading:15361250-Humans,
pubmed-meshheading:15361250-Immunologic Memory,
pubmed-meshheading:15361250-Leishmania major,
pubmed-meshheading:15361250-Leishmaniasis, Cutaneous,
pubmed-meshheading:15361250-Mice,
pubmed-meshheading:15361250-Mice, Inbred Strains,
pubmed-meshheading:15361250-Protozoan Vaccines,
pubmed-meshheading:15361250-Th1 Cells
|
pubmed:year |
2004
|
pubmed:articleTitle |
The development of effector and memory T cells in cutaneous leishmaniasis: the implications for vaccine development.
|
pubmed:affiliation |
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA, USA. pscott@vet.upenn.edu
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.,
Review
|